Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C05A	ANTROLIN	B	Nifedipine - 0.3%, Lidocaine - 1.5%		Cream	1,333,092 L.L
N05BA08	ANXYL	G	Bromazepam - 3mg	3mg	Tablet, scored	167,660 L.L
S03AA07	API-CIPROCIN	G	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops	530,818 L.L
S01EE01	API-LOPROST	G	Latanoprost - 0.005%	0.01%	Drops	447,500 L.L
R05CB06	API-MUCOL	G	Ambroxol HCl - 15mg/5ml	15mg/5ml	Syrup	326,554 L.L
S01CA01	API-TOBRASON	G	Dexamethasone - 1mg/ml, Tobramycin - 3mg/ml		Drops suspension	294,302 L.L
S01CA01	API-TOBRASON	G	Dexamethasone - 1mg/g, Tobramycin - 3mg/g		Ointment	243,235 L.L
A10AB06	APIDRA	BioTech	Insulin glulisine - 100IU/ml	100IU/ml	Injectable solution	2,221,372 L.L
A10AB06	APIDRA SOLOSTAR	BioTech	Insulin glulisine - 100IU/ml	100IU/ml	Injectable solution	3,942,834 L.L
B01AF02	APIXEL	G	Apixaban - 5mg	5mg	Tablet, film coated	1,750,579 L.L
B01AF02	APIXEL	G	Apixaban - 2.5mg	2.5mg	Tablet, film coated	1,750,579 L.L
N02CX01	APIZINE	G	Pizotifen - 0.25mg/5ml	0.25mg/5ml	Syrup	505,541 L.L
L02BX03	APO-ABIRATERONE	G	Abiraterone acetate - 500mg	500mg	Tablet, film coated	46,110,590 L.L
M05BA04	APO-ALENDRONATE	G	Alendronate (monosodium trihydrate) - 70mg	70mg	Tablet	981,005 L.L
G04CA01	APO-ALFUZOSIN	G	Alfuzosin HCl - 10mg	10mg	Tablet	2,331,567 L.L
M04AA01	APO-ALLOPURINOL	G	Allopurinol - 100mg	100mg	Tablet	331,929 L.L
M04AA01	APO-ALLOPURINOL	G	Allopurinol - 300mg	300mg	Tablet	626,231 L.L
L02BG03	APO-ANASTROZOLE	G	Anastrozole - 1mg	1mg	Tablet	2,615,118 L.L
B01AF02	APO-APIXABAN	G	Apixaban - 5mg	5mg	Tablet	3,084,119 L.L
B01AF02	APO-APIXABAN	G	Apixaban - 2.5mg	2.5mg	Tablet	3,084,119 L.L
C07AB03	APO-ATENOL	G	Atenolol - 50mg	50mg	Tablet	327,898 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 60mg	60mg	Capsule	4,731,669 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 40mg	40mg	Capsule	4,114,846 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 25mg	25mg	Capsule	3,703,630 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 10mg	10mg	Capsule	2,981,987 L.L
C10AA05	APO-ATORVASTATIN	G	Atorvastatin (calcium) - 20mg	20mg	Tablet	1,088,378 L.L
C10AA05	APO-ATORVASTATIN	G	Atorvastatin (calcium) - 40mg	40mg	Tablet	1,405,390 L.L
C10AA05	APO-ATORVASTATIN	G	Atorvastatin (calcium) - 10mg	10mg	Tablet	889,624 L.L
J01FA10	APO-AZITHROMYCIN Z	G	Azithromycin - 250mg	250mg	Tablet	481,096 L.L
C07AB07	APO-BISOPROLOL	G	Bisoprolol fumarate - 5mg	5mg	Tablet	923,220 L.L

...

187